Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: A phase II study

Tumori

Volumn 85, Issue 6, 1999, Pages 473-477

  Bertuccelli, Maurizio ^a,c   Falcone, Alfredo ^b   Campoccia, Silvana ^b   Conti, Monica ^b   Brunetti, Isa ^b   Caramella, Davide ^d   Giulianotti, PierCristoforo ^d   Mosca, Franco ^d   Bartolozzi, Carlo ^d   Conte, PierFranco ^b  

^a Livorno Hospital   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Istituto Toscano Tumori   (Italy)

^d NONE

Author keywords

Colorectal cancer; Floxuridine; Hepatic metastases; Intrahepatic chemotherapy

Indexed keywords

CARMUSTINE; DEXAMETHASONE; FLOXURIDINE; FOLINIC ACID; MITOMYCIN C;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER GRADING; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER METASTASIS; LIVER TOXICITY; MALE; PHASE 2 CLINICAL TRIAL; STOMATITIS;

EID: 0033393792     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169908500609     Document Type: Article

References (27)

1. Cohen A.M., Scaeffer N., Higgins J.: Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy. Cancer, 57: 1115-1117, 1986.
2. Chang A.E., Scneider P.D., Sugarbaker P.H.: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann. Surg., 1987; 206: 685.
3. Falcone A., Danesi R., Dargenio F., Pfanner E., Brunetti I., Del Tacca M., Nethershell A.B.W., Conte P.F.: Intravenous azydothimidine with fluorouracil and leucovorin: a phase II study in previously untreated metastatic colorectal cancer patients. J. Clin. Oncol., 14: 729-736, 1996.
4. Foster J.H., Berman M.M.: Solid liver tumours. Major Probl. Clin. Surg., 22: 1, 1987.
5. Harmantas A., Rotstein L.E., Langer B.: Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Cancer, 78: 1639-1644, 1996.
6. Hohn D.C., Stagg R.J., Friedman MA.: A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group Trial. J. Clin. Oncol., 7: 1646, 1989.
7. Kaplan E.L., Meier P.: Non parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
8. Kemeny N.: Regional chemotherapy of hepatic metastasis. J. Exp. Clin. Cancer Res., suppl. 8: 158, 1989.
9. Kemeny N., Buyse M., Rougier P.H., Carlson R., Allen-Mersh T., O'C'onnell M.: A meta-analysis of hepatic arterial infusion in patients with liver metastases from colorectal cancer, (abs) Proc. ASCO: 205, 1996 (Meta-analysis Group in Cancer).
10. Kemeny N., Cohen A., Bertino JR., Sigurdson E.R., Botet J., Oderman P.: Continuous intrahepatic infusion of floxuridine and leucoverin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. Cancer, 65: 2446-2450, 1990.
11. Kemeny N., Conti J.A., Cohen A. ,Campana A., Huang Y.: Phase II study of hepatic arterial floxuridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal cancer. J. Clin. Oncol., 12: 2288-2295, 1994.
12. Kemeny N., Daly G., Reichman B., Geller N., Botet J., Oderman P.: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann. Intern. Med. 107: 459-465, 1987.
13. Kemeny N., Golbey R.A.: A chemotherapeutic approach to colorectal carcinoma. In: Neoplasms of the Colon, Rectum and Anus, Stearns M.R. Jr. (Ed.), pp. 155-168, John Wiley, New York, 1980.
14. Kemeny N., Seiter K., Niedzwiecki D.: A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colo-rectal cancer. Cancer, 69: 327-334, 1992.
15. Levi F., Zidani R., Vannetzel J.M.: Chronomodulated versus fixed infusion rate delivery of ambulatory chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with colorectal cancer metastases. A randomized multiinstitutional trial. J. Natl. Cancer Inst., 86: 1608-1617, 1994.
16. Lorenz M., Hottenrott C., Inglis R., Kirkowa-Reimann M.: Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment. Gan To Kagaku Ryoho, 16: 3662, 1989.
17. Martin J.K., O'Connell M.J., Wiends H.S.: Intraarterial floxuridine vs. systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch. Surg., 125: 1022, 1990.
18. Rougier P.H., Laplanche J., Huguier M.: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J. Clin. Oncol., 10: 1112, 1992.
19. Safi F.: Continuous simultaneous intraarterial (IA) and intravenous (IV) therapy of metastases of colorectal carcinoma. Results of prospective randomized trial. Proc. ASCO, 11: A490, 1992.
20. Safi F., Bittner R., Rocher S., Schuhmaker K.: Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Cancer, 64: 379, 1989.
21. Scheithauer W., Rosen H., Kornek G.: Randomized comparison of combination chemotherapy plus supportive care with supportive are alone in patients with metastatic colorectal cancer. Br. J. Cancer, 306: 752-755, 1993.
22. Seiter K., Kemeny N., Cohen A., Sigurdson E., Niedzwiecki D.: A randomized trial of hepatic arterial FUDR + mitomycin + BCNU (FMB) versus FUDR alone in previously treated liver metastases from colorectal cancer (Abst). Proc. ASCO, 140, 1991.
23. Silverberg E., Lubera J.S.: Cancer statistics 1989. CA.A. Cancer J. Clin., 39: 3-21, 1989.
24. Steele G., Ravikumar T.S.: Resection of the hepatic metastases from colorectal cancer. Ann. Surg., 210: 127-38, 1989.
25. Wagman L.D., Kemeny M.M., Leong L.: A prospective randomized evaluation of the treatment of colorectal metastatic to the liver. J. Clin. Oncol., 8: 1885, 1990.
26. WHO handbook for Reporting Results of Cancer Treatment. Offset publication No. 48. WHO, Geneva, 1979.
27. Yasuhiro S., Masahiro Y., Akira W., Isao N.: Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. J. Clin. Oncol., 11: 909-913, 1993.